Lisa Jackson

16PUBLICATIONS
93CO-AUTHORS
Epidemiological modellingInnate immunityMedical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 08, 2026
Retrospective cohort study of mRNA COVID-19 vaccine-associated enhanced disease in the Vaccine Safety Datalink, 2021-23.

|Feb 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.

Noemia S Lima, Lauren McCormick, Samuel Li

|Nov 19, 2025
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.

David Fitz-Patrick, Donald S McVinnie, Lisa A Jackson

|Oct 10, 2025
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

David M Dobrzynski, Daniel S Graciaa, Tara M Babu

|Apr 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

Robert L Atmar, Kirsten E Lyke, Christine M Posavad

|Oct 16, 2024
Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration.

Tara M Babu, Lisa A Jackson, Hana M El Sahly

Pageof 3

Frequent Collaborators

7 joint publications

John H Beigel

5 joint publications

Nicole Doria-Rose

5 joint publications

Evan J Anderson

3 joint publications

Barney S Graham